The Perpetual Impact of COVID-19 on the Geriatric Population's Quality of Life and Potential Preventive and Therapeutic Measures in Unani Medicine: An Evidence-based Review

Author:

Ara Shabnam Anjum1,Akhlaq Shaheen1,Ahmad Bilal1,Haque Merajul1,Fazil Mohammad1,Akram Usama1,Sayeed Ahmad1,Ali Khan Asim1

Affiliation:

1. Hakim Ajmal Khan Institute for Literary & Historical Research in Unani Medicine, Dr. M.A. Ansari Health Centre, Jamia Millia Islamia, New Delhi Under Central Council for Research in Unani Medicine, Ministry of Ayush, Government of India, New Delhi, India

Abstract

Background: COVID-19 pandemic has affected the elderly population more severely than many other patient groups. Due to their constitutional weakness and co-morbidities, geriatric populations are more prone to complications and adverse outcomes, especially with a high viral load. The Unani system of medicine encompasses several guidelines for the prevention and treatment of epidemics, which are stratified for different types of people with respect to age, geography, and health status, among others. Objective: Since Unani drugs are both safe and efficient, it has been found that demand for them has surged since COVID. This paper aims to discuss the various immunomodulatory, longevity-promoting agents, and organ-specific tonics specified in Unani medicine for the care of the elderly, which may be helpful during epidemics, and also, to present the scientific evidence of their efficacy. Methods: A thorough assessment of the available literature was carried out utilizing several electronic databases, including PubMed, Science Direct, Web of Science, Wiley Online, Google Scholar, and Springer Link, using the terms "Geriatrics," "Elderly," "SARS-CoV-2," "Unani," and many others, up until October 2022. A total of 61 pertinent reviews were included. To gather information on epidemics and their specific response in geriatrics, monographs in Urdu, Arabic, and English were explored in addition to classic Unani texts such Al-Qanun fit Tibb (The Canon of Medicine), Kamil-us-Sana'at (Liber Regius), Kitab al-Hawi fit Tibb (Liber Continence), and others. Plant names were confirmed by “The Plant List” (www.theplantlist.org). Results: During pandemics, Unani medicine aims to promote and preserve the health of the elderly by regulating six important factors (Asbāb Sitta Ḍarūriyya), which include adopting a specific diet, regimen and drugs as effective prophylactic strategies. However, the role of Unani medicine in immunological regulation relies on major organ protection, viz., general body tonic, nervine tonic, heart tonic, and liver tonic. Several Unani single drugs, such as Sibr (Aloe barbadensis Mill.), Zafran (Crocus sativus L.), and Mur (Commiphora myrrh Nees.), and formulations, such as Khameera Marwareed, Tiryaq-i- Arba, and Habb-i- Jadawar have also been found to be very effective in validated scientific preclinical and clinical studies. Furthermore, Unani drugs have anti-inflammatory, analgesic, and tonic actions, contributing to their holistic efficacy. Conclusion: It is observed in this review that Unani medicine employs a holistic approach to the health protection of the elderly. There are various dietary recommendations, lifestyle modifications, regimental therapy, and pharmacotherapy prescribed as per the individual’s requirements and needs to reduce geriatric mortality in times of epidemics. Modern pharmacological studies have discovered many bioactive compounds in health-protective drugs prescribed in Unani medicine, such as Vitis vinifera L., Ziziphus jujube Mill., and many others, further substantiating the literature.

Publisher

Bentham Science Publishers Ltd.

Subject

Complementary and alternative medicine,Drug Discovery

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3